Edwards Lifesciences Reports First Quarter Results
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2026.Highlights and OutlookQ1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7%Q1 TAVR sales grew 14.4% to $1.20 billion1; constant currency2 sales grew 11.0%Q1 TMTT sales of $173 million1,3, driven by repair and replacement therapiesQ1 EPS of $0.661; adjusted2 EPS of $0.781Raising FY 2026 constant currency2 sales growth guidance to 9% to 11% from 8% to 10%Raising FY 2026 adjusted2 EPS guidance midpoint; new range of $2.95 to $3.05 from $2.90 to $3.05Renewed clinical focus on proactive disease management with differentiated SAPIEN TAVRCompleted $500 million Accelerated Share Repurchase“Building on a year in 2025 marked by solid financial performance and strategic progress, we delivered another strong quarter in Q1, achieving 12.7% sales growth, which reflects the impact and durability of our focused strategy. We remain dedicated to
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Edwards Lifesciences (EW) had its "hold (c)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026Business Wire
- Artisan Mid Cap Fund Q1 2026 Portfolio Activity [Seeking Alpha]Seeking Alpha
- Edwards Lifesciences (EW) was given a new $95.00 price target by Mizuho.MarketBeat
EW
Earnings
- 4/23/26 - Beat
EW
Sec Filings
- 4/23/26 - Form 8-K
- 4/9/26 - Form 4
- 4/6/26 - Form 4
- EW's page on the SEC website